3Gecchini S, Carozzi F, Confortini M, et al. Persistent human papilloma virus infection as an indicator of risk of recurrence of high-grade cervical intraepithdial neoplasia treated by the loop electrosurgical excision procedure [J]. Tumori, 2004, 90 (2):225～228.
4Houfflin Debarge V, Collinet P, Vinatier D, et al. Value of human papillomavirus testing after conization by loop dectrosurgical excision for high-grade squamous intraepithelial lesions[J]. Gynecol Oncol, 2003, 90(3): 587～592.
5Nagai N, Mukai K, Oshita T, et al. Human papillomavirus DNA status after loop excision for cervical intraepithelial neoplasia grade Ⅲ-A prospective study [J]. Int J Mol Med, 2004, 13(4): 589～593.
6Alonso I, Torne A, Puig-Tintore LM, et al. Pre- and postconization high-risk HPV testing predicts residual/recurrent disease in patients treated for GIN 2-3[J]. Gynecol Oncol, 2006, 103 (2): 631～636.
7Wright TC Jr, Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia[J]. Am J Obstet Gynecol, 2003, 189(1):295～304.
8Natee J, Therasakvichaya S, Boriboonhirunsam D. Prevalence and risk factors for residual cervical neoplasia in subsequent hysterectomy following LEEP or conization [J]. J Med Assoc Thai, 2005, 88(10): 1344～1348.
9Lu CH, Liu FS, Kuo CJ, et al. Prediction of persistence or recurrence after conization for cervical intraepithelial neoplasia Ⅲ [J]. Obstet Gynecol, 2006, 107(4): 830～835.
10Dietrich CS 3rd, Yancey MK, Miyazawa K, et al. Risk factors for early cytologic abnormalities after loop electrosurgical excision procedure[J]. Obstet Gynecol, 2002, 99(2): 188～192.
